Information about Quantum Biotech Early Stage
My details
*
*
*

Quantum Biotech Early Stage (SRL)

Company information

Status
Active

Enterprise number

BE0789.524.966

VAT liability
Yes
Established
09-08-2022
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Other business support service activities n.e.c.
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Quantum Biotech Early Stage

2024 2023
Profit/Loss 2,733 691 % 346
Equity 253,078 1 % 250,346
Gross margin 23,334 639 % 3,159

Publications from Quantum Biotech Early Stage

Date Publication
11-08-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Quantum Biotech Early Stage?
The VAT number of Quantum Biotech Early Stage is BE 0789.524.966.
Wat is the PEPPOL ID of Quantum Biotech Early Stage?
There is no information available about the PEPPOL ID of Quantum Biotech Early Stage or the company is not yet registered on the PEPPOL network.
When was Quantum Biotech Early Stage founded?
Quantum Biotech Early Stage was founded on 09-08-2022.
What is the address of Quantum Biotech Early Stage?
The current registered office of Quantum Biotech Early Stage is located at Stapsteenweg(Heu) 1/a, 9070 Destelbergen.
When was the last time Quantum Biotech Early Stage filed their annual financial statements?
The most recent financial statements of Quantum Biotech Early Stage were filed on 16-10-2025.
How many employees does Quantum Biotech Early Stage have?
There are currently no employees working at Quantum Biotech Early Stage or no workforce information is available.
What is the annual turnover of Quantum Biotech Early Stage?
At the time of its most recent financial statements, Quantum Biotech Early Stage did not publish any turnover figures. Quantum Biotech Early Stage reported a gross margin of €23,334.33.